Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Hikma Pharmaceuticals (HIK) Share News

LONDON BRIEFING: M&S warns on cost hit to profit but is well placed

25th May 2022 08:28

(Alliance News) - Marks & Spencer on Wednesday reported a swing to profit for the year ended April 2, but the clothing, homewares and food retailer cautioned on profit in the year ahead, amid the war in Ukraine and investment plans. Read More

IN BRIEF: Hikma Pharmaceuticals Chief Executive Siggi Olafsson resigns

24th May 2022 10:29

Hikma Pharmaceuticals PLC - London-based pharmaceutical company - Says Siggi Olafsson has resigned as chief executive officer and from the board to "pursue other opportunities." Adds he will remain available to the company until he resigns on June 24. Olafsson was appointed as CEO in 2018. Before he joined Hikma, he was president of peer firm Actavis Generics until 2014 from 2012. Read More

LONDON BRIEFING: Barclays launches delayed GBP1 billion share buyback

24th May 2022 08:24

(Alliance News) - Barclays said it will kick off a GBP1.00 billion share buyback programme on Tuesday. The programme, initially announced in February, had been delayed in March after the bank admitted it sold more financial products to investors than it was allowed to. Read More

UK shareholder meetings calendar - next 7 days

13th May 2022 16:01

LONDON BROKER RATINGS: Downgrades for Centrica and Rathbones

6th May 2022 09:47

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday: Read More

LONDON MARKET MIDDAY: Pound slips as BoE opts for quarter-point hike

5th May 2022 12:11

(Alliance News) - Stock prices in London were higher, while the pound was flat, on Thursday, after the Bank of England as expected raised UK interest rates by a quarter percentage point. Read More

TOP NEWS: Hikma shares fall 10% on delay to Jazz Pharmaceuticals drug

5th May 2022 09:24

(Alliance News) - Shares in Hikma Pharmaceuticals PLC fell early Thursday, after the drugmaker downgraded guidance for its Generics business due to the delayed launch of a generic of the Xyrem treatment for narcolepsy. Read More

LONDON MARKET OPEN: Mondi and Shell lift FTSE 100 after strong updates

5th May 2022 08:58

(Alliance News) - Stock prices in London opened sharply higher on Thursday after the US Federal reserve assuaged fears over further aggressive monetary policy tightening, while positive updates from Mondi and Shell boosted the FTSE 100. Read More

IN BRIEF: Hikma says has not entered license agreement with Opiant

29th Apr 2022 17:44

Hikma Pharmaceuticals PLC - London-based generic drugmaker - Confirms that it has not entered into any transaction with Opiant Pharmaceutical UK, following a PR Newswire announcement issued on Friday. The release said Opiant and Hikma entered into a commercialisation and license agreement for OPNT003, Nasal Nalmefene, in Europe and the UK. Read More

LONDON MARKET CLOSE: Stocks end volatile April on high note

29th Apr 2022 17:01

(Alliance News) - Stocks in London on Friday ended a volatile month of April in a positive fashion, amid a continued rush of company earnings, while markets in the US sank as high-profile tech names disappointed. Read More

Hikma Pharmaceuticals notes "slow" start for Generics business in 2022

29th Apr 2022 09:09

(Alliance News) - Hikma Pharmaceuticals PLC said on Friday that both its Injectables and Branded businesses have performed well at the start of the year but noted its Generics business has experienced some headwinds. Read More

LONDON BRIEFING: Pearson has positive first quarter, buys language app

29th Apr 2022 08:25

(Alliance News) - Educational materials publisher Pearson on Friday provided a positive update on first quarter trading, while also announcing a new acquisition. Read More

UK dividends calendar - next 7 days

21st Apr 2022 16:06

IN BRIEF: Hikma Pharmaceuticals completes Custopharm deal

21st Apr 2022 14:37

Hikma Pharmaceuticals PLC - London-based generic drugmaker - Completes acquisition of Custopharm Inc from Water Street Healthcare Partners, following approval from the US Federal Trade Commission. Back in September, Hikma agreed to buy the California-based generic injectable products company for a total of up to USD425 million. Deal will add up to 13 approved products and additional pipeline products. Read More

IN BRIEF: Hikma gets preliminary US approval for Custopharm acquisition

20th Apr 2022 09:16

Hikma Pharmaceuticals PLC - London-based generic drugmaker - Receives preliminary approval from the US Federal Trade Commission for its planned acquisition of Custopharm Inc. Back in September, Hikma agreed to buy the California, US-based generic injectable products company for a total of up to USD425 million. Read More

FTSE 100 Latest

Value10,462.13

Change108.29